The presentation will be given by
About Apellis
Investor Contact:
apellis@argotpartners.com
+1 212.600.1902
2021 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.02 USD | -2.73% |
|
+6.92% | -33.13% |
06-28 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
06-28 | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
The presentation will be given by
About Apellis
Investor Contact:
apellis@argotpartners.com
+1 212.600.1902
2021 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-33.13% | 4.99B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.32% | 32.76B | |
+79.34% | 29.46B | |
-12.27% | 16.31B | |
+3.74% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |